ID

30762

Beschreibung

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring; ODM derived from: https://clinicaltrials.gov/show/NCT01053104

Link

https://clinicaltrials.gov/show/NCT01053104

Stichworte

Versionen (1)
  1. 20.06.18 20.06.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

20. Juni 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Metastatic Colorectal Cancer NCT01053104

Englisch

Eligibility Metastatic Colorectal Cancer NCT01053104

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
metastatic colorectal or breast cancer patients commencing treatment on one of four specified regimens
Beschreibung

Colorectal cancer metastatic | Secondary malignant neoplasm of female breast | Start Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0948380
UMLS CUI [2]
C0346993
UMLS CUI [3,1]
C0439659
UMLS CUI [3,2]
C0087111
for metastatic colorectal cancer:
Beschreibung

Colorectal cancer metastatic

Datentyp

boolean

Alias
UMLS CUI [1]
C0948380
capecitabine 2000mg/m2 d 1-14, q 3 weekly and oxaliplatin 130mg/m2 d1 q 3 weekly (capox)
Beschreibung

Capecitabine Dosage | Oxaliplatin Dosage | CAPOX Regimen

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0671970
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0069717
UMLS CUI [2,2]
C0178602
UMLS CUI [3]
C1879915
capecitabine 2500mg/m2 d 1-14, q 3 weekly
Beschreibung

Capecitabine Dosage

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0671970
UMLS CUI [1,2]
C0178602
for metastatic breast cancer:
Beschreibung

Secondary malignant neoplasm of female breast

Datentyp

boolean

Alias
UMLS CUI [1]
C0346993
capecitabine 2000mg/m2d 1-14, q 3 weekly
Beschreibung

Capecitabine Dosage

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0671970
UMLS CUI [1,2]
C0178602
capecitabine 2000mg/m2 d 1-14, q 3 weekly and docetaxel 75mg/m2 d1 q 3 weekly
Beschreibung

Capecitabine Dosage | Docetaxel Dosage

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0671970
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0246415
UMLS CUI [2,2]
C0178602
age > 18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
fit to start at full (100%) starting dose of all drugs
Beschreibung

Fit Pharmaceutical Preparations Dose Full

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0424576
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0443225
able and willing to use mobile phone
Beschreibung

Able to operate mobile phone | Use of Mobile Phone Willing

Datentyp

boolean

Alias
UMLS CUI [1]
C4274610
UMLS CUI [2,1]
C1524063
UMLS CUI [2,2]
C1136360
UMLS CUI [2,3]
C0600109
reasonable renal, liver and bone marrow function
Beschreibung

Renal function | Liver function | Bone Marrow function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
UMLS CUI [3,1]
C0005953
UMLS CUI [3,2]
C0031843
absolute neutrophil count (anc) >1.5 x 109/l
Beschreibung

Absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
platelet count > 100 x 109/l
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
total bilirubin <1.5 uln
Beschreibung

Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
alt, ast < 2.5 x uln
Beschreibung

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
alkaline phosphatase < 2.5 x uln
Beschreibung

Alkaline phosphatase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201850
no obvious contra indications to capecitabine or oxaliplatin or docetaxel
Beschreibung

Absence Medical contraindication Capecitabine | Absence Medical contraindication Oxaliplatin | Absence Medical contraindication Docetaxel

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1301624
UMLS CUI [1,3]
C0671970
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C1301624
UMLS CUI [2,3]
C0069717
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C1301624
UMLS CUI [3,3]
C0246415
patients must also be able to read, write and understand english.
Beschreibung

Able to read English Language | Able to write English Language | Comprehension English Language

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0586740
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0584993
UMLS CUI [2,2]
C0376245
UMLS CUI [3,1]
C0233733
UMLS CUI [3,2]
C0376245
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who live in an area of no vodafone or orange mobile phone network - -
Beschreibung

Residence | Mobile Phone Network Lacking | Other Coding

Datentyp

boolean

Alias
UMLS CUI [1]
C0237096
UMLS CUI [2,1]
C1136360
UMLS CUI [2,2]
C1882071
UMLS CUI [2,3]
C0332268
UMLS CUI [3]
C3846158
patients participating in other cancer treatment trials
Beschreibung

Study Subject Participation Status | Cancer treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0920425
moderate or severe renal impairment [creatinine clearance <30ml/min (calculated according to cockroft-gault formula)]
Beschreibung

Renal Insufficiency Moderate | Renal Insufficiency Severe | Estimation of creatinine clearance by Cockcroft-Gault formula

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205081
UMLS CUI [2,1]
C1565489
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C2711451
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Metastatic Colorectal Cancer NCT01053104

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal cancer metastatic | Secondary malignant neoplasm of female breast | Start Therapeutic procedure
Item
metastatic colorectal or breast cancer patients commencing treatment on one of four specified regimens
boolean
C0948380 (UMLS CUI [1])
C0346993 (UMLS CUI [2])
C0439659 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
Colorectal cancer metastatic
Item
for metastatic colorectal cancer:
boolean
C0948380 (UMLS CUI [1])
Capecitabine Dosage | Oxaliplatin Dosage | CAPOX Regimen
Item
capecitabine 2000mg/m2 d 1-14, q 3 weekly and oxaliplatin 130mg/m2 d1 q 3 weekly (capox)
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0069717 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C1879915 (UMLS CUI [3])
Capecitabine Dosage
Item
capecitabine 2500mg/m2 d 1-14, q 3 weekly
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Secondary malignant neoplasm of female breast
Item
for metastatic breast cancer:
boolean
C0346993 (UMLS CUI [1])
Capecitabine Dosage
Item
capecitabine 2000mg/m2d 1-14, q 3 weekly
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Capecitabine Dosage | Docetaxel Dosage
Item
capecitabine 2000mg/m2 d 1-14, q 3 weekly and docetaxel 75mg/m2 d1 q 3 weekly
boolean
C0671970 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0246415 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Fit Pharmaceutical Preparations Dose Full
Item
fit to start at full (100%) starting dose of all drugs
boolean
C0424576 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0443225 (UMLS CUI [1,4])
Able to operate mobile phone | Use of Mobile Phone Willing
Item
able and willing to use mobile phone
boolean
C4274610 (UMLS CUI [1])
C1524063 (UMLS CUI [2,1])
C1136360 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Renal function | Liver function | Bone Marrow function
Item
reasonable renal, liver and bone marrow function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0005953 (UMLS CUI [3,1])
C0031843 (UMLS CUI [3,2])
Absolute neutrophil count
Item
absolute neutrophil count (anc) >1.5 x 109/l
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count > 100 x 109/l
boolean
C0032181 (UMLS CUI [1])
Serum total bilirubin measurement
Item
total bilirubin <1.5 uln
boolean
C1278039 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
alt, ast < 2.5 x uln
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Alkaline phosphatase measurement
Item
alkaline phosphatase < 2.5 x uln
boolean
C0201850 (UMLS CUI [1])
Absence Medical contraindication Capecitabine | Absence Medical contraindication Oxaliplatin | Absence Medical contraindication Docetaxel
Item
no obvious contra indications to capecitabine or oxaliplatin or docetaxel
boolean
C0332197 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C0671970 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
C0069717 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C1301624 (UMLS CUI [3,2])
C0246415 (UMLS CUI [3,3])
Able to read English Language | Able to write English Language | Comprehension English Language
Item
patients must also be able to read, write and understand english.
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0233733 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Residence | Mobile Phone Network Lacking | Other Coding
Item
patients who live in an area of no vodafone or orange mobile phone network - -
boolean
C0237096 (UMLS CUI [1])
C1136360 (UMLS CUI [2,1])
C1882071 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
C3846158 (UMLS CUI [3])
Study Subject Participation Status | Cancer treatment
Item
patients participating in other cancer treatment trials
boolean
C2348568 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
Renal Insufficiency Moderate | Renal Insufficiency Severe | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
moderate or severe renal impairment [creatinine clearance <30ml/min (calculated according to cockroft-gault formula)]
boolean
C1565489 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C1565489 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C2711451 (UMLS CUI [3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video